acridine orange has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitos, I; Mády, G; Simonyi, M; Visy, J; Zsila, F | 1 |
| Ellison-Hughes, GM; Papaspyros, S; Smith, AJ; Steele, DS; Walmsley, R | 1 |
2 other study(ies) available for acridine orange and imatinib mesylate
| Article | Year |
|---|---|
Selective binding of imatinib to the genetic variants of human alpha1-acid glycoprotein.
Topics: Acridine Orange; Benzamides; Binding Sites; Circular Dichroism; Humans; Imatinib Mesylate; Imipramine; Naphthalenesulfonates; Orosomucoid; Piperazines; Polymorphism, Genetic; Protein Binding; Protein Kinase Inhibitors; Pyrimidines; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 2006 |
Imatinib Mesylate Induces Necroptotic Cell Death and Impairs Autophagic Flux in Human Cardiac Progenitor Cells.
Topics: Acridine Orange; Apoptosis; Autophagy; Cell Death; Humans; Imatinib Mesylate; Protein Kinase Inhibitors; Stem Cells; Wortmannin | 2022 |